Clinical value of the wild-type estrogen receptor beta expression in breast cancer.
about
Phosphorylation of estrogen receptor alpha serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer.Identification of estrogen receptor dimer selective ligands reveals growth-inhibitory effects on cells that co-express ERα and ERβERbeta in breast cancer--onlooker, passive player, or active protector?Expression of oestrogen receptor beta (ERbeta1) protein in human breast cancer biopsiesExpression of estrogen receptor beta in the breast carcinoma of BRCA1 mutation carriersERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancerOestrogen receptor beta in breast cancer: good, bad or still too early to tell?Estrogen receptor-beta expression in invasive breast cancer in relation to molecular phenotype: results from the Nurses' Health Study.Ligand-dependent differences in estrogen receptor beta-interacting proteins identified in lung adenocarcinoma cells corresponds to estrogenic responses.Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifenThe favourable prognostic value of oestrogen receptor beta immunohistochemical expression in breast cancer.Loss of ERbeta expression as a common step in estrogen-dependent tumor progressionImpact of estrogen receptor-β expression on breast cancer prognosis: a meta-analysis.ER beta inhibits proliferation and invasion of breast cancer cellsERβ overexpression results in endocrine therapy resistance and poor prognosis in postmenopausal ERα-positive breast cancer patients.Expression of oestrogen receptor-beta in oestrogen receptor-alpha negative human breast tumours.Wild-type oestrogen receptor beta (ERbeta1) mRNA and protein expression in Tamoxifen-treated post-menopausal breast cancersEstrogen receptor beta as a prognostic factor in breast cancer patients: A systematic review and meta-analysis.Intermolecular interactions identify ligand-selective activity of estrogen receptor alpha/beta dimers.A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study.Development, characterization, and applications of a novel estrogen receptor beta monoclonal antibody.Immunohistochemical expression of hormone receptors in melanoma of pregnant women, nonpregnant women, and men.Support of a bi-faceted role of estrogen receptor β (ERβ) in ERα-positive breast cancer cellsAromatase inhibitors and other novel agents in breast cancer treatment.Expression of sex steroid receptor subtypes in normal and malignant breast tissue - a pilot study in postmenopausal women.Expression of estrogen receptor beta wild-type and its variant ERbetacx/beta2 is correlated with better prognosis in breast cancer.ERβ inhibits cyclin dependent kinases 1 and 7 in triple negative breast cancer.Evaluation of seven oestrogen receptor beta antibodies for immunohistochemistry, western blotting, and flow cytometry in human breast tissue.
P2860
Q24813594-214AD485-0700-415E-B9C7-CEBA7F99DABCQ28480546-85379042-04D4-47ED-88A3-0243932FD3AAQ30438399-8617B8FE-9C9B-497C-A5A2-6E7C6BC11DAFQ31040434-2E7EC93D-FFD8-4251-A5D4-FB639C6F9782Q33327785-B66AD688-646A-4D20-ADC7-0047C71B4E57Q34334131-933CD38C-C9A6-48FF-83DE-CDB8D9462A4CQ34642084-2CD605B1-1AAF-4D21-86BA-10C2344E357BQ34663257-79BB7AE0-7263-4DD7-BC6A-AF7FC5B5701CQ35338975-361CE97E-D84D-42C0-8F8F-4D069F2A7A17Q35558946-4462ED22-5226-4298-BC5E-9CE7BE3495D4Q35587582-63AA0951-2D47-41DD-9195-CCA5661D6107Q35888377-E420C6ED-1A93-4293-B32E-A248529F26B8Q35931634-883391D2-E22D-4DA6-9B13-772AE1348D01Q36089436-E23C3210-8BA0-4A48-972A-13C59E2AE660Q36524735-0B72026F-A859-4866-9F27-8C405303BB23Q36612259-19123E08-6AC6-4168-A0E5-DA2DAB172E2EQ36695878-A8DC3EE8-CB95-4E1A-8A1B-3325D77C8037Q36962972-21FB3C4D-7DE2-4E30-9A0E-9066CA176825Q36999937-7DC6D30E-46B0-455B-8061-E925B222362AQ37038621-739E5479-577A-4C23-83C0-AAB74875164EQ37049590-85C6C47A-529A-4147-86BB-CF8FF727749DQ37227695-2B06B7A6-9D05-4C7F-A682-C3DA3E8BBEBCQ37624907-0A06F55D-9C58-414C-A2E3-D88AFDA33864Q40409345-1E4217DC-235B-466C-82F3-5F3D55F64315Q46933035-9AF8BC3A-DD06-4E1F-9B68-2A707AAC407EQ46954407-986C4E02-2D8D-4D46-8089-3B3D6D4E295FQ47134638-1E1F8767-2F3B-4886-AE93-31E304D62258Q52861622-FB3FA5AF-5687-452C-B6A1-5C5C98D6F244
P2860
Clinical value of the wild-type estrogen receptor beta expression in breast cancer.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Clinical value of the wild-type estrogen receptor beta expression in breast cancer.
@ast
Clinical value of the wild-type estrogen receptor beta expression in breast cancer.
@en
type
label
Clinical value of the wild-type estrogen receptor beta expression in breast cancer.
@ast
Clinical value of the wild-type estrogen receptor beta expression in breast cancer.
@en
prefLabel
Clinical value of the wild-type estrogen receptor beta expression in breast cancer.
@ast
Clinical value of the wild-type estrogen receptor beta expression in breast cancer.
@en
P2093
P1433
P1476
Clinical value of the wild-type estrogen receptor beta expression in breast cancer.
@en
P2093
Kobayashi S
Muramatsu M
Yamashita H
P304
P356
10.1016/S0304-3835(00)00680-7
P407
P577
2001-02-01T00:00:00Z